• 1. Emerging 2D hybrid nanomaterials: towards enhanced sensitive and selective conductometric gas sensors at room temperature
  Hanie Hashtroudi,Ian D. R. Mackinnon J. Mater. Chem. C, 2020,8, 13108-13126
• 2. Excellent electrochemical performance of LiFe0.4Mn0.6PO4 microspheres produced using a double carbon coating process?
  Yong Ping Huang,Tao Tao,Zheng Chen,Wei Han,Ying Wu,Chunjiang Kuang,Shaoxiong Zhou,Ying Chen J. Mater. Chem. A, 2014,2, 18831-18837
• 3. Emerging investigator series: heterogeneous reactions of sulfur dioxide on mineral dust nanoparticles: from single component to mixed components?
  Tao Wang,Yangyang Liu,Yue Deng,Hongbo Fu,Jianmin Chen Environ. Sci.: Nano, 2018,5, 1821-1833
• 4. Fast synthesis of copper nanoclusters through the use of hydrogen peroxide additive and their application for the fluorescence detection of Hg2+ in water samples?
  Liao Xiaoqing,Li Ruiyi,Li Zaijun,Sun Xiulan,Wang Zhouping,Liu Junkang New J. Chem., 2015,39, 5240-5248
• 5. EWOD-driven droplet microfluidic device integrated with optoelectronic tweezers as an automated platform for cellular isolation and analysis?
  Gaurav J. Shah,Eric P.-Y. Chiou,Ming C. Wu,Chang-Jin “CJ” Kim Lab Chip, 2009,9, 1732-1739

• Solvents and Organic Chemicals Organic Compounds Benzenoids Phenol ethers Phenol ethers
• Solvents and Organic Chemicals Organic Compounds Benzenoids Phenol ethers

Professional Introduction to Compound with CAS No. 51837-55-9 and Product Name: 2-(4-bromophenoxy)-N-(2-hydroxyethyl)acetamide

Compound with the CAS number 51837-55-9 and the product name 2-(4-bromophenoxy)-N-(2-hydroxyethyl)acetamide represents a significant area of interest in the field of chemical biology and pharmaceutical research. This compound, characterized by its unique structural features, has garnered attention due to its potential applications in drug development and molecular studies. The presence of a 4-bromophenoxy group and an N-(2-hydroxyethyl)acetamide moiety suggests a versatile chemical profile that could be exploited for various biochemical interactions.

The 4-bromophenoxy group is a key structural element that often serves as a pharmacophore in medicinal chemistry. This moiety is known for its ability to interact with biological targets, making it a valuable component in the design of novel therapeutic agents. The bromine atom, in particular, introduces a site for further functionalization, allowing chemists to tailor the compound's properties for specific applications. Recent studies have highlighted the utility of brominated aromatic compounds in the development of kinase inhibitors and other targeted therapies, underscoring the relevance of this structural feature.

On the other hand, the N-(2-hydroxyethyl)acetamide component contributes to the compound's solubility and bioavailability, which are critical factors in pharmaceutical formulations. This amide group is commonly found in drugs due to its ability to enhance metabolic stability while maintaining good water solubility. The hydroxyl group attached to the ethyl chain further increases the compound's reactivity, providing multiple sites for chemical modification. Such modifications are often employed to optimize pharmacokinetic profiles and improve therapeutic efficacy.

Recent advancements in computational chemistry have enabled more precise predictions of molecular interactions, which has significantly enhanced the design process for compounds like 2-(4-bromophenoxy)-N-(2-hydroxyethyl)acetamide. Molecular docking studies have shown that this compound can bind effectively to various protein targets, including enzymes and receptors involved in critical biological pathways. For instance, preliminary research suggests that it may interact with serine/threonine kinases, which are implicated in cancer progression and inflammatory diseases. Such interactions could potentially lead to the development of novel therapeutic strategies.

In addition to its potential as a drug candidate, 2-(4-bromophenoxy)-N-(2-hydroxyethyl)acetamide has been explored as an intermediate in synthetic chemistry. Its unique structure allows for diverse chemical transformations, making it a valuable building block for more complex molecules. Researchers have utilized this compound to synthesize derivatives with enhanced biological activity, further demonstrating its versatility. The ability to modify both the 4-bromophenoxy and N-(2-hydroxyethyl)acetamide groups provides chemists with a high degree of flexibility in designing tailored compounds for specific research or therapeutic purposes.

The compound's potential applications extend beyond drug development into agrochemicals and material science. For example, certain derivatives of this class have shown promise as antimicrobial agents, addressing growing concerns about antibiotic resistance. The structural motifs present in 2-(4-bromophenoxy)-N-(2-hydroxyethyl)acetamide are well-suited for disrupting bacterial cell wall synthesis or inhibiting essential metabolic pathways. Such properties make it an attractive candidate for further investigation in this field.

From a synthetic perspective, the preparation of 2-(4-bromophenoxy)-N-(2-hydroxyethyl)acetamide involves multi-step reactions that highlight modern synthetic methodologies. Techniques such as palladium-catalyzed cross-coupling reactions have been employed to introduce the 4-bromophenoxy group efficiently. Meanwhile, nucleophilic substitution reactions have been used to incorporate the N-(2-hydroxyethyl)acetamide moiety. These synthetic strategies not only showcase the compound's accessibility but also reflect ongoing advancements in organic synthesis that continue to streamline complex molecule construction.

The growing interest in this compound is also driven by its compatibility with modern screening technologies used in drug discovery. High-throughput screening (HTS) platforms are increasingly employed to identify promising candidates based on their binding affinity to target proteins. The favorable physicochemical properties of 2-(4-bromophenoxy)-N-(2-hydroxyethyl)acetamide, such as its solubility and stability, make it an ideal candidate for HTS assays. This compatibility accelerates the process of identifying lead compounds that can be further optimized through structure-activity relationship (SAR) studies.

In conclusion, 51837-55-9 and its corresponding product name 2-(4-bromophenoxy)-N-(2-hydroxyethyl)acetamide represent a compelling subject of study in chemical biology and pharmaceutical research. The unique combination of structural features offers numerous possibilities for therapeutic applications, synthetic modifications, and material science innovations. As research continues to uncover new biological targets and synthetic methodologies, compounds like these will undoubtedly play a crucial role in advancing scientific understanding and developing next-generation solutions.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)